1,095 results on '"Von Minckwitz, Gunter"'
Search Results
102. Neoadjuvant Clinical Trials for the Treatment of Primary Breast Cancer: The Experience of the German Study Groups
103. Incorporating Agents that Target HER2 in the Neoadjuvant Setting
104. Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33)
105. Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
106. Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference
107. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
108. Molecular basis for the development of novel taxanes in the treatment of metastatic breast cancer
109. Neoadjuvant breast cancer therapy: the German experience
110. Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
111. Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial
112. Predictive Factors for Response to Neoadjuvant Therapy in Breast Cancer
113. Monounsaturated fatty acids in serum triacylglycerols are associated with response to neoadjuvant chemotherapy in breast cancer patients
114. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial
115. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
116. Breakthrough for neoadjuvant chemotherapy
117. The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs
118. Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review
119. Surgical Procedures After Neoadjuvant Chemotherapy in Operable Breast Cancer: Results of the GEPARDUO Trial
120. A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer – GABG-IV B-93
121. A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer
122. Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial
123. Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
124. Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
125. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells
126. Treatment with Trastuzumab Beyond Progression
127. Darbepoetin Alfa as Primary Prophylaxis of Anemia in Patients with Breast Cancer Treated Preoperatively with Docetaxel/Doxorubicin/Cyclophosphamide
128. Evidence-based treatment of metastatic breast cancer – 2006 recommendations by the AGO Breast Commission
129. CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: A randomised trial (GABG trial IV-A-93)
130. Update on neoadjuvant/preoperative therapy of breast cancer: experiences from the German Breast Group
131. Bevacizumab in Neoadjuvant Treatment for Breast Cancer
132. Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings
133. Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
134. Abstract GS1-02: Phase III study of palbociclib combined with endocrine therapy (ET) in patients with hormone-receptor-positive (HR+), HER2-negative primary breast cancerand with high relapse risk after neoadjuvant chemotherapy (NACT): First results from PENELOPE-B
135. Adjuvant Trastuzumab in HER2-Positive Breast Cancer
136. PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
137. Biomarker data from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer.
138. Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
139. Trastuzumab Single-Drug Therapy after Failure of Cytotoxic Treatment for Metastatic Breast Cancer
140. Locoregional treatment of primary breast cancer: Consensus recommendations from an International Expert Panel
141. The Reawakening of Bendamustine - Also in Breast Cancer?
142. Preoperative (neoadjuvant) systemic treatment of breast cancer
143. The role of early expression of inducible nitric oxide synthase in human breast cancer
144. Docetaxel (Taxotere®) zur Therapie des Mammakarzinoms: Höchste Wirksamkeit bei moderaten Nebenwirkungen
145. Neoadjuvant Vinorelbine–Capecitabine Versus Docetaxel–Doxorubicin–Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial
146. Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study
147. Effective Inhibition of Aromatase Inhibitor-Associated Bone Loss by Zoledronic Acid in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole: Zo-Fast Study Results
148. Docetaxel as Neoadjuvant Therapy in Early-Stage or Locally Advanced Breast Cancer: A Viewpoint
149. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44
150. Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.